Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANKL Combined with Chemotherapy in Advanced NSCLC
NCT02370017Phase 2Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Feb 2015
- Primary completion
- Aug 2018
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ANKL in non-small cell lung cancer (NSCLC), sponsored by The Catholic University of Korea. Status: unknown.
02
Drugs
ANKL
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02370017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02370017.